InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Carr Edward, 首席财务官. Director active across 2 companies, notably Abeona Therapeutics INC.. Aggregated, 3 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €26k. Activity tracked since 10 August 2021. The latest transaction was filed on 12 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Carr Edward
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
16,182 股@ US$17.88100.0% 占其流量Common StockSEC:0001273351-26-000004:0
29,122 股@ US$1.0506100.0% 占其流量Common stockSEC:0001493152-21-025082:0
238,000 股0Common stockSEC:0001493152-21-019498:0
3 条申报中的 3 条
About Carr Edward
Edward Carr is the Chief Financial Officer at ABEONA THERAPEUTICS INC. In this role, he oversees the company's financial operations, including financial planning, risk management, and compliance. With deep expertise in finance and corporate strategy, he plays a crucial role in making financial decisions that support the organization's growth and profitability. His leadership is essential for ensuring the financial health of the company.
